<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>2943953</identifier>
<setSpec>0210-5187</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Castel, T</dc:author>
<dc:author>Lecha, M</dc:author>
<dc:author>Castro, J</dc:author>
<dc:author>Mascaró, J M</dc:author>
<dc:description xml:lang="en">The results of the treatment of psoriatic erythroderma are variable in different references. The authors describe the treatment of three patients and emphasize the immuno-modulatory action of etretinate on polymorphonuclears, monocytes and Langerhans cells and the possibility of an action on prostaglandins.</dc:description>
<dc:type>Case Reports</dc:type>
<dc:language>es</dc:language>
<dc:date>1986 </dc:date>
<dc:title xml:lang="es">Efectos secundarios inhabituales en enfermos con eritrodermia psoriásica tratados con etretinato (RO 10-9359).</dc:title>
<dc:title xml:lang="en">[Unusual side effects in patients with psoriatic erythroderma treated with etretinate (RO 10-9359)].</dc:title>
<dc:publisher>Medicina cutanea ibero-latino-americana</dc:publisher>
</metadata>
</record>
</pubmed-document>
